Right Drug Dose Now Act of 2024

The Right Drug Dose Now Act of 2024 requires the Health and Human Services Secretary to create a National Action Plan to prevent adverse drug events, focusing on drug-gene interactions. It mandates updated training for healthcare providers (including doctors, pharmacists, and genetic specialists) on pharmacogenomic testing and its role in avoiding harmful drug reactions. The bill also directs electronic health record (EHR) systems to automatically flag drug-gene interaction risks before prescriptions are finalized and improves FDA adverse event reporting by adding options for patients to report gene-related reactions. These changes directly affect healthcare providers, EHR developers, and the FDA’s drug safety monitoring system.